phrykt

CVS HEALTH Corp (CVS): who owns it and who trades it

As of Nov 16, 2026, CVS insiders reported 8 open-market sales worth $324M and 1 purchase worth $2M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Larry Robbins (Director), with $317M. 11 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling CVS Health

From the latest filings

Overall: more selling than buying. Insiders and famous investors mostly sold. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns CVS

2,053 funds and institutions reported CVS shares worth $117B at the end of Q2 2026, about 89% of the company. The largest holder is BlackRock, Inc. with 9.7%.

Funds and institutions (13F) 89%Everyone else 11%

10 largest owners, by share of the company

BlackRock, Inc.9.7%
Vanguard Capital Management LLC6.5%
Capital World Investors5.9%
State Street Corp4.7%
Dodge & Cox3.9%
Wellington Management Group LLP2.6%
Geode Capital Management, LLC2.3%
FMR LLC (Fidelity)2.3%
Vanguard Portfolio Management LLC2.1%
Capital Research Global Investors1.9%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.123.22M9.66%$12.7B-2%
Vanguard Capital Management LLC83.32M6.53%$8.6B+1%
Capital World Investors74.95M5.87%$7.8B-3%
State Street Corp60.28M4.72%$6.2B+2%
Dodge & Cox50.01M3.92%$5.2B-3%
Wellington Management Group LLP33.80M2.65%$3.5B+50%
Geode Capital Management, LLC29.90M2.34%$3.1B+1%
FMR LLC (Fidelity)28.92M2.27%$3B-7%
Vanguard Portfolio Management LLC26.64M2.09%$2.8B+2%
Capital Research Global Investors24.33M1.91%$2.5B+22%
T. Rowe Price Associates24.20M1.90%$2.5B+2%
Bank of America Corp23.19M1.82%$2.4B+148%
JPMorgan Chase & Co22.11M1.73%$2.3B–
Invesco Ltd.20.60M1.61%$2.1B-18%
Morgan Stanley18.61M1.46%$1.9B+4%
Norges Bank18.04M1.41%$1.9B–
Capital International Investors15.39M1.21%$1.6BNo change
Goldman Sachs Group Inc13.41M1.05%$1.4B+6%
Charles Schwab Investment Management Inc13.26M1.04%$1.4B-3%
Davis Selected Advisers11.87M0.93%$1.2B-3%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, CVS insiders reported $2M of open-market purchases and $324M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$2M
1 trades, 1 people
Sales, 12 months
$324M
8 trades, 2 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Nov 6, 2026
Filed Nov 6, 2026

Purchases and sales by month

$324M$324MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 6, 2026Prem S ShahVice presidentPurchase23,855$83.89$2MForm 4
May 21, 2026Larry RobbinsDirectorSale370,462$93.45$34.6MForm 4
May 20, 2026Larry RobbinsDirectorSale66,881$95.67$6.4MForm 4
May 20, 2026Larry RobbinsDirectorSale800$96.28$77KForm 4
May 20, 2026Larry RobbinsDirectorSale797,628$93.48$74.6MForm 4
May 20, 2026Larry RobbinsDirectorSale152,691$94.81$14.5MForm 4
May 19, 2026Larry RobbinsDirectorSale1.98M$94.45$187MForm 4
May 19, 2026Larry RobbinsDirectorSale151$95.18$14.4KForm 4
May 8, 2026Tilak MandadiVice presidentSale69,551$89.58$6.2MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Larry RobbinsDirector–$317MMay 21, 2026
Tilak MandadiEVP, Chief Exp & Tech Officer–$6.2MMay 8, 2026
Prem S ShahEVP and Group President$2M–Nov 6, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

CVS short interest

Low short interest. 1.4% of CVS shares are sold short: about 1 share in 72. Over the last 12 reports the number of shares short went down 8%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 17.88M CVS shares were sold short, 1.4% of the shares outstanding, up 10.4% from the report before. At the average daily volume of 6.42M shares, buying them all back would take about 2.8 trading days (days to cover).

Shares short, % of all shares

1.40%May 15Oct 301.90%

Days to cover

2.8May 15Oct 303.4

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202617.88M1.40%+10%6.42M2.8
Oct 15, 202616.19M1.27%-2%10.33M1.6
Sep 30, 202616.47M1.29%+2%9.94M1.7
Sep 15, 202616.12M1.26%-11%5.13M3.1
Aug 31, 202618.11M1.42%+8%6.46M2.8
Aug 14, 202616.82M1.32%-10%9.34M1.8
Jul 31, 202618.68M1.46%-4%7.74M2.4
Jul 15, 202619.52M1.53%-2%7.19M2.7
Jun 30, 202619.94M1.56%-14%8.65M2.3
Jun 15, 202623.19M1.82%+31%8.56M2.7
May 29, 202617.76M1.39%-9%7.45M2.4
May 15, 202619.52M1.53%+10%9.89M2.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded CVS

Since Nov 17, 2024, 11 members of Congress reported 5 purchases and 10 sales of CVS. The latest was a purchase by Alan Armstrong on Mar 27, 2026, reported Jul 21, 2026.

Purchases 5Sales 10

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Mar 27, 2026Alan Armstrong (R-OK)Purchase$1K–$15KSelfJul 21, 2026Report
Jan 29, 2026John Boozman (R-AR)Purchase$1K–$15KJointFeb 15, 2026Report
Nov 21, 2025Dwight Evans (D-PA)Sale$1K–$15KSelfDec 19, 2025Report
Oct 31, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseNov 21, 2025Report
Oct 30, 2025Lisa C. McClain (R-MI)Sale$1K–$15KSpouseNov 21, 2025Report
Oct 30, 2025Lisa C. McClain (R-MI)Purchase$1K–$15KSpouseNov 21, 2025Report
Sep 23, 2025Val T. Hoyle (D-OR)Sale$1K–$15KSpouseOct 10, 2025Report
Aug 8, 2025Adam Smith (D-WA)Sale$1K–$15KSelfAug 8, 2025Report
May 15, 2025Robert P. Bresnahan, Jr. (R-PA)Sale$1K–$15KSelfMay 31, 2025Report
May 12, 2025Jefferson Shreve (R-IN)Sale$15K–$50KSelfJun 22, 2025Report
Apr 1, 2025Julie Johnson (D-TX)Sale$1K–$15KJointMay 14, 2025Report
Feb 25, 2025Robert P. Bresnahan, Jr. (R-PA)Purchase$1K–$15KSelfMar 27, 2025Report
Jan 31, 2025J. French Hill (R-AR)Sale$15K–$50KSelfFeb 4, 2025Report
Jan 24, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfFeb 11, 2025Report
Jan 15, 2025Julie Johnson (D-TX)Partial sale$1K–$15KJointFeb 12, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

CVS Health company events

CVS Health filed 10 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026AnnouncementShared information with investors. Filing
  2. Nov 4, 2026ResultsReleased financial results. Filing
  3. Aug 17, 2026LeadershipLarry M. Robbins notified the Board of Directors of CVS Health Corporation of his resignation from the Board, effective immediately. Filing
  4. Aug 5, 2026ResultsReleased financial results. Filing
  5. May 18, 2026LeadershipCVS Health Corporation held its 2026 Annual Meeting of Stockholders. Filing
  6. May 6, 2026ResultsReleased financial results. Filing
  7. Mar 19, 2026LeadershipThe Board of Directors of CVS Health Corporation elected John E. Gallina to serve on the Board, effective March 19, 2026. Filing
  8. Feb 10, 2026ResultsReleased financial results. Filing
  9. Dec 9, 2025AnnouncementShared information with investors. Filing
  10. Nov 20, 2025AnnouncementThe Board of Directors of CVS Health Corporation appointed J. David Joyner, President and Chief Executive Officer of the Company, to the additional role of Chair of the Board, effective January 1, 2026. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

CVS Health financials

Famous investors that hold CVS

11 of the 50 well-known investors we track reported holding CVS in their latest 13F filing. The largest position is Richard Pzena's, worth $882M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Richard Pzena · Pzena Investment ManagementQ3 202610.30M$882M2.6%-13%
Jim Simons · Renaissance TechnologiesQ3 20262.72M$233M0.3%+518%
Prem Watsa · Fairfax Financial HoldingsQ3 20262.71M$232M8.8%No change
Israel Englander · Millennium ManagementQ3 20261.50M$128M0.1%-31%
Larry Robbins · Glenview Capital ManagementQ3 20261.28M$110M1.9%-73%
Ken Griffin · Citadel AdvisorsQ3 2026815,797$69.9M0.0%-83%
Jeremy Grantham · GMOQ3 2026545,737$46.8M0.1%+1%
Ray Dalio · Bridgewater AssociatesQ3 2026378,152$32.4M0.1%-14%
Bill Nygren · Harris Associates (Oakmark)Q3 2026260,727$22.3M0.0%-22%
Ken Fisher · Fisher Asset ManagementQ3 202697,886$8.4M0.0%+6%
Lee Ainslie · Maverick CapitalQ3 202619,246$1.6M0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about CVS HEALTH Corp (CVS) stock

Who owns the most CVS stock?

The largest reported owner of CVS HEALTH Corp (CVS) is BlackRock, Inc., with 9.7% of the company. In total, 2,053 funds and institutions reported holding CVS at the end of Q2 2026, together about 89% of the shares. See the largest owners.

Are CVS insiders buying or selling?

In the last 12 months, CVS insiders reported 1 open-market purchase worth $2M and 8 sales worth $324M. The latest trade was on Nov 6, 2026. See every trade.

What is the short interest in CVS?

As of Oct 30, 2026, 17.88M CVS shares were sold short, 1.4% of the shares outstanding, up 10.4% from the report before. At the average daily volume of 6.42M shares, buying them all back would take about 2.8 trading days (days to cover). See the history.

Have members of Congress traded CVS?

Yes. 11 members of Congress reported 5 purchases and 10 sales of CVS since Nov 17, 2024. The latest was reported on Jul 21, 2026. See the trades.

Which famous investors hold CVS?

11 of the 50 well-known investors we track reported CVS in their latest 13F filing, including Richard Pzena, Jim Simons, Prem Watsa. The largest position is worth $882M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.